Intravenous Administration of Toll-Like Receptor Inhibitory Peptide 1 is Effective for the Treatment of Systemic Lupus Erythematosus in a Mus musculus Model-Reference-Cited by-同舟云学术

Intravenous Administration of Toll-Like Receptor Inhibitory Peptide 1 is Effective for the Treatment of Systemic Lupus Erythematosus in a Mus musculus Model

Published:2021-07-01 Issue:3 Volume:28 Page:133-142
ISSN:2093-940X
Container-title:Journal of Rheumatic Diseases
language:en
Short-container-title:J Rheum Dis

Author:

Baek Wook-Young¹²,Lee Sung-Min¹,Lee Sang-Won¹,Son In-Ok¹,Choi Sangdun²,Suh Chang-Hee¹²^ORCID

Affiliation:

1. Department of Rheumatology, Ajou University School of Medicine, Suwon, Korea

2. Department of Molecular Science and Technology, Ajou University, Suwon, Korea

Funder

Korea Health Industry Development Institute

Publisher

Korean College of Rheumatology

Link

http://pdf.medrang.co.kr/JRD/2021/028/JRD028-03-133.pdf

Reference35 articles.

1. Systemic Lupus Erythematosus

2. Klippel JH. Systemic lupus erythematosus: demographics, prognosis, and outcome. J Rheumatol Suppl 1997;48:67-71.

3. Petri M. Long-term outcomes in lupus. Am J Manag Care 2001;7(16 Suppl):S480-5.

4. Toblli JE, Trigo M, Mendoza G, Fellner JP, Genaro O, Houssay R, et al. [Hematologic manifestations in systemic lupus erythematosus. Experience collected from 150 cases]. Rev Clin Esp 1983;169:257-61. Spanish.

5. Environmental Influences on Systemic Lupus Erythematosus Expression

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tofacitinib therapy in systemic lupus erythematosus with arthritis: a retrospective study;Clinical Rheumatology;2024-08-13

2. Decoding the connection between SLE and DNA Sensors: A comprehensive review;International Immunopharmacology;2024-08

3. Associations of toll-like receptor polymorphisms with systemic lupus erythematosus: A meta-analysis;Heliyon;2024-03

4. Treatment of active systemic lupus erythematosus with baricitinib: A meta-analysis of randomized controlled trials;Lupus;2023-10-18

5. TLR9: A friend or a foe;Life Sciences;2022-10